Prophylactic or pre-emptive therapies to prevent relapse after allogeneic hematopoietic stem cell transplantation

被引:0
作者
Kako, Shinichi [1 ]
机构
[1] Jichi Med Univ, Dept Internal Med, Div Hematol, Saitama Med Ctr, 1-847 Amanuma,Omiya Ku, Saitama, Saitama 3308503, Japan
关键词
ACUTE LYMPHOBLASTIC-LEUKEMIA; DONOR LYMPHOCYTE INFUSION; ACUTE MYELOID-LEUKEMIA; MULTIPLE-MYELOMA; HYPER-CVAD; CONDITIONING REGIMENS; PROGNOSTIC RELEVANCE; WORKING PARTY; DEXAMETHASONE; LENALIDOMIDE;
D O I
10.1007/s12185-023-03631-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Allogeneic hematopoietic stem cell transplantation is a potent curative treatment for hematological malignancies, but relapse is still a major problem. Donor lymphocyte infusion (DLI) and maintenance therapies after transplantation are promising strategies to reduce the risk of relapse. DLI augments the graft-versus-tumor effect by directly adding allo-reactive donor lymphocytes, and has been used in relapsed patients. In this Progress in Hematology (PIH), we will focus on prophylactic or pre-emptive DLI, including DLI from a haploidentical donor. On the other hand, specific drugs, which are used in maintenance therapies for each disease, kill tumor cells directly and/or immunologically by stimulating immune cells. Maintenance therapies should be started early after transplantation without severe myelosuppression. Molecularly targeted drugs are therefore suitable for use in maintenance therapies, and are reviewed in this PIH. The optimal application of these strategies has not yet been established. However, important evidence regarding their efficacies, adverse events, and effects on immune systems is accumulating, and could help to improve outcomes in allogeneic transplantation.
引用
收藏
页码:155 / 157
页数:3
相关论文
共 50 条
[31]   Prognosis and risk factors for central nervous system relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia [J].
Chen, Qi ;
Zhu, Xiao-Lu ;
Zhao, Xin ;
Liu, Xiao ;
Fu, Hai-Xia ;
Zhang, Yuan-Yuan ;
Chen, Yu-Hong ;
Mo, Xiao-Dong ;
Han, Wei ;
Chen, Huan ;
Yan, Chen-Hua ;
Wang, Yu ;
Chang, Ying-Jun ;
Xu, Lan-Ping ;
Huang, Xiao-Jun ;
Zhang, Xiao-Hui .
ANNALS OF HEMATOLOGY, 2021, 100 (02) :505-516
[32]   Cells to prevent/treat relapse following allogeneic stem cell transplantation [J].
Dietz, Andrew C. ;
Wayne, Alan S. .
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2017, :708-715
[33]   Isolated Breast Relapse of Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation [J].
Demirsoy, Esra Terzi ;
Atesoglu, Elif Birtas ;
Tarkun, Pinar ;
Geduk, Ayfer ;
Erdem, Busra Ersan ;
Hacihanefioglu, Abdullah ;
Ercin, Mehmet Cengiz .
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2016, 32 :S201-S204
[34]   Isolated Breast Relapse of Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation [J].
Esra Terzi Demirsoy ;
Elif Birtas Atesoglu ;
Pinar Tarkun ;
Ayfer Gedük ;
Büşra Erşan Erdem ;
Abdullah Hacihanefioglu ;
Mehmet Cengiz Erçin .
Indian Journal of Hematology and Blood Transfusion, 2016, 32 :201-204
[35]   Application of prophylactic or pre-emptive therapy after allogeneic transplantation for high-risk patients with t(8;21) acute myeloid leukemia [J].
Guo, Wenwen ;
Liu, Xin ;
Wang, Mingyang ;
Liu, Jia ;
Cao, Yigeng ;
Zheng, Yawei ;
Zhai, Weihua ;
Chen, Xin ;
Zhang, Rongli ;
Ma, Qiaoling ;
Yang, Donglin ;
Wei, Jialin ;
He, Yi ;
Pang, Aiming ;
Feng, Sizhou ;
Han, Mingzhe ;
Jiang, Erlie .
HEMATOLOGY, 2023, 28 (01)
[36]   Strategies and Challenges for Pharmacological Maintenance Therapies after Allogeneic Hematopoietic Cell Transplantation [J].
DeFilipp, Zachariah ;
Chen, Yi-Bin .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (12) :2134-2140
[37]   Risk Factors Influencing Outcome of Acute Leukemia Patients Who Experience Relapse After Allogeneic Hematopoietic Stem-Cell Transplantation [J].
El-Ghammaz, Amro M. S. ;
El-Razzaz, Mostafa K. .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (04) :E183-E190
[38]   Novel Biomarkers for Outcome After Allogeneic Hematopoietic Stem Cell Transplantation [J].
Chen, Sophia ;
Zeiser, Robert .
FRONTIERS IN IMMUNOLOGY, 2020, 11
[39]   Maintenance therapy after allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma [J].
Kawamura, Koji .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (02) :193-200
[40]   Allogeneic hematopoietic stem cell transplantation in elderly [J].
Castagna, Luca ;
Blaise, Didier ;
Furst, Sabine .
BULLETIN DU CANCER, 2011, 98 (08) :915-925